Ticlid

   
Google
 
Web NewDrugInformation.com

Ticlid


Drug - Ticlid
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ticlopidine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 250MG
The potency of the active ingredient(s), Ticlopidine Hydrochloride. May repeat for multiple part products.

Applicant - ROCHE PALO
The firm name holding legal responsibility for Ticlid. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019979
The FDA assigned number to Ticlid. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Ticlid. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 31, 1991
The date Ticlid was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Ticlid. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Ticlid is in. Format is RX, OTC, DISCN.

Applicant Full Name - Roche Palo Alto Llc
The full name of the firm holding legal responsibility for the new application of Ticlid.

Ticlid